Q3 2026
Nov 10, 2026
The stock fell 1.4% after earnings, a roughly flat reaction. Results included record cannabis revenue and higher sequential EBITDA, while Canadian branded growth remained below the company’s mid-single-digit target and gross margins faced pressure from weaker trim pricing.
Key takeaways
- Cannabis revenue reached a record $55 million; consolidated sales were $67 million, up 5% sequentially.
- Net income was $10 million, or $0.08 per share. Adjusted EBITDA rose 18% sequentially to $18.2 million, equal to 27% of sales; operating cash flow was $9.5 million.
- International export sales grew 75% year over year to $20.8 million. The company said it remained supply-constrained and that the 9% year-over-year decline in average net selling price reflected a shift toward bulk flower, not lower pricing for EU GMP-compliant product.
- Softer Canadian trim conditions weighed on gross margins; management said spot trim prices were down about 75% year over year in Q3, and expected normalization to begin in Q4.
- Canadian branded sales were $25.3 million, with average net selling prices up 6% year over year. Management acknowledged it had not achieved its goal of growing in line with the Canadian market at mid-single digits in recent quarters.
Q2 2026
Aug 12, 2026
Village Farms' shares surged 16.8% post-earnings, driven by record cannabis revenues, strong margin expansion from their Delta facility, and significant growth in international export sales, notably benefiting from their EU GMP certified production advantage.
Key takeaways
- Achieved five consecutive quarters of positive net income and EPS since divesting legacy produce business.
- Nearly 10 percentage points year-over-year gross margin expansion attributed to record harvest yields, operating efficiencies, and favorable sales mix.
- Adjusted EBITDA rose meaningfully to $15.4 million, driven by a record Q2 cannabis segment performance.
- International export sales grew 74% year-over-year and 43% sequentially, supported by the world's largest EU GMP certified cannabis facility.
- Continued market share gains in Canadian convenience categories and strong positioning in German and broader European markets.
Q1 2026
May 13, 2026
Village Farms' 1Q26 results beat expectations as total net sales rose 27% year-over-year, driven by a 171% surge in international export sales and sustained price stability in key markets. The 3.9% stock lift reflects investor approval of expanding global cannabis operations and capacity enhancements.
Key takeaways
- Total net sales increased 27% year-over-year, with a modest 2% sequential gain despite capacity constraints ahead of planned expansion.
- Adjusted EBITDA more than doubled (+118% YoY), supporting the company’s fourth consecutive quarter of positive net income.
- International exports reached nearly $15 million, up 171% year-over-year and 60% sequentially, led by growth in Germany where Village Farms holds multiple top cultivars.
- Pricing for EU GMP-compliant flower remained stable in international markets, contrasting with broader industry price compression.
- Expanded production capacity at the British Columbia facility now positions Village Farms as having the world’s largest EU GMP-certified cannabis operation, reinforcing competitive advantages.
Q3 2025
Nov 10, 2025
Village Farms International reported strong third-quarter results, marked by a 21% increase in consolidated net sales year-over-year and record adjusted EBITDA margins, reinforcing its position as a leader in the cannabis market.
Key takeaways
- Consolidated net sales grew 21% year-over-year, reaching a record $64.1 million in the Canadian cannabis segment.
- Net income from continuing operations increased to $10.8 million, up nearly 10% sequentially from the previous quarter.
- Adjusted EBITDA hit a new high of $20.7 million, representing an adjusted EBITDA margin of 31%.
- International medical cannabis sales surged over 750% year-over-year, highlighting rapid growth in Germany and anticipated expansion into new markets.
- A 40 metric ton expansion project is underway, expected to increase annual production capacity by approximately 33% by early 2027.